Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial. [electronic resource]
Producer: 20181023Description: 2113-2126 p. digitalISSN:- 1527-3350
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Benzofurans -- therapeutic use
- Drug Combinations
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles -- therapeutic use
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- Quinoxalines -- therapeutic use
- Ribavirin -- therapeutic use
- Sofosbuvir -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.